Imported Disease Annotations - CTDObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | C2orf88 | Human | juvenile rheumatoid arthritis | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:19565504 | |
|
Imported Disease Annotations - CTDObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | C2orf88 | Human | juvenile rheumatoid arthritis | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:19565504 | |
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
2. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:12477932 | PMID:16189514 | PMID:16303743 | PMID:16344560 | PMID:17207965 | PMID:21988832 | PMID:22344221 | PMID:23115245 | PMID:23455922 | PMID:23996002 | PMID:24962325 | PMID:25416956 |
PMID:27028580 | PMID:27503909 | PMID:29117863 | PMID:31343991 | PMID:31515488 | PMID:32296183 | PMID:32393512 | PMID:32707033 |
C2orf88 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1700019D03Rik (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
C9h2orf88 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LOC102003714 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
C13H2orf88 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
C37H2orf88 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CUNH2orf88 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
C15H2orf88 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CUNH2orf88 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CUNH2orf88 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in C2orf88
83 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 2q31.1-33.2(chr2:174898848-203941548)x1 | copy number loss | See cases [RCV000050980] | Chr2:174898848..203941548 [GRCh38] Chr2:175763576..204806271 [GRCh37] Chr2:175471822..204514516 [NCBI36] Chr2:2q31.1-33.2 |
pathogenic |
GRCh38/hg38 2q31.1-33.1(chr2:176304445-202039790)x1 | copy number loss | See cases [RCV000052558] | Chr2:176304445..202039790 [GRCh38] Chr2:177169173..202904513 [GRCh37] Chr2:176877419..202612758 [NCBI36] Chr2:2q31.1-33.1 |
pathogenic |
GRCh38/hg38 2q31.2-33.1(chr2:177874070-198525492)x1 | copy number loss | See cases [RCV000052559] | Chr2:177874070..198525492 [GRCh38] Chr2:178738797..199390216 [GRCh37] Chr2:178447043..199098461 [NCBI36] Chr2:2q31.2-33.1 |
pathogenic |
GRCh38/hg38 2q32.2-37.3(chr2:188818195-242065208)x3 | copy number gain | See cases [RCV000052958] | Chr2:188818195..242065208 [GRCh38] Chr2:189682921..243007359 [GRCh37] Chr2:189391166..242656032 [NCBI36] Chr2:2q32.2-37.3 |
pathogenic |
NM_005259.3(MSTN):c.373+5G>A | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000008144] | Chr2:190062219 [GRCh38] Chr2:190926945 [GRCh37] Chr2:2q32.2 |
pathogenic |
NM_005259.3(MSTN):c.163G>A (p.Ala55Thr) | single nucleotide variant | MSTN-related disorder [RCV003974941]|Myostatin-related muscle hypertrophy [RCV000055913]|not provided [RCV004707901] | Chr2:190062434 [GRCh38] Chr2:190927160 [GRCh37] Chr2:2q32.2 |
benign |
NM_005259.3(MSTN):c.458A>G (p.Lys153Arg) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000055914]|not provided [RCV001610341] | Chr2:190060351 [GRCh38] Chr2:190925077 [GRCh37] Chr2:2q32.2 |
pathogenic|benign |
GRCh38/hg38 2q31.3-36.2(chr2:180513793-224302848)x3 | copy number gain | See cases [RCV000139446] | Chr2:180513793..224302848 [GRCh38] Chr2:181378520..225167565 [GRCh37] Chr2:181086765..224875809 [NCBI36] Chr2:2q31.3-36.2 |
pathogenic |
GRCh38/hg38 2q31.2-32.3(chr2:177827730-195125329)x1 | copy number loss | See cases [RCV000141735] | Chr2:177827730..195125329 [GRCh38] Chr2:178692457..195990053 [GRCh37] Chr2:178400703..195698298 [NCBI36] Chr2:2q31.2-32.3 |
pathogenic |
GRCh38/hg38 2q32.1-33.1(chr2:186027472-201059372)x1 | copy number loss | See cases [RCV000135876] | Chr2:186027472..201059372 [GRCh38] Chr2:186892199..201924095 [GRCh37] Chr2:186600444..201632340 [NCBI36] Chr2:2q32.1-33.1 |
pathogenic |
GRCh38/hg38 2q31.3-32.3(chr2:181758701-192015392)x1 | copy number loss | See cases [RCV000138253] | Chr2:181758701..192015392 [GRCh38] Chr2:182623428..192880118 [GRCh37] Chr2:182331673..192588363 [NCBI36] Chr2:2q31.3-32.3 |
pathogenic |
GRCh38/hg38 2q31.1-32.3(chr2:176086763-193201970)x1 | copy number loss | See cases [RCV000143484] | Chr2:176086763..193201970 [GRCh38] Chr2:176951491..194066696 [GRCh37] Chr2:176659737..193774941 [NCBI36] Chr2:2q31.1-32.3 |
pathogenic |
NM_005259.3(MSTN):c.306C>T (p.Ser102=) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000289636]|not provided [RCV000884311] | Chr2:190062291 [GRCh38] Chr2:190927017 [GRCh37] Chr2:2q32.2 |
benign|likely benign |
NM_005259.3(MSTN):c.748-3C>T | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000372367] | Chr2:190057641 [GRCh38] Chr2:190922367 [GRCh37] Chr2:2q32.2 |
likely benign|uncertain significance |
NM_005259.3(MSTN):c.551C>T (p.Thr184Ile) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000319193] | Chr2:190060258 [GRCh38] Chr2:190924984 [GRCh37] Chr2:2q32.2 |
benign|uncertain significance |
NM_005259.3(MSTN):c.263G>A (p.Arg88Gln) | single nucleotide variant | MSTN-related disorder [RCV003940339]|Myostatin-related muscle hypertrophy [RCV000347027]|not provided [RCV000762305] | Chr2:190062334 [GRCh38] Chr2:190927060 [GRCh37] Chr2:2q32.2 |
benign|likely benign|uncertain significance |
GRCh38/hg38 2q32.2-37.3(chr2:189436149-241841232)x3 | copy number gain | See cases [RCV000142307] | Chr2:189436149..241841232 [GRCh38] Chr2:190300875..242783384 [GRCh37] Chr2:190009120..242432057 [NCBI36] Chr2:2q32.2-37.3 |
pathogenic |
NM_005259.3(MSTN):c.386T>G (p.Met129Arg) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000403660]|not provided [RCV000879806] | Chr2:190060423 [GRCh38] Chr2:190925149 [GRCh37] Chr2:2q32.2 |
benign|likely benign |
NM_005259.3(MSTN):c.466C>A (p.Leu156Ile) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000283902] | Chr2:190060343 [GRCh38] Chr2:190925069 [GRCh37] Chr2:2q32.2 |
likely benign |
GRCh37/hg19 2q31.1-32.3(chr2:177315153-196375520)x1 | copy number loss | See cases [RCV000239432] | Chr2:177315153..196375520 [GRCh37] Chr2:2q31.1-32.3 |
pathogenic |
NM_005259.3(MSTN):c.*1203G>C | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000278586] | Chr2:190056055 [GRCh38] Chr2:190920781 [GRCh37] Chr2:2q32.2 |
benign |
NM_005259.3(MSTN):c.674T>C (p.Ile225Thr) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000280530]|not provided [RCV000891357] | Chr2:190060135 [GRCh38] Chr2:190924861 [GRCh37] Chr2:2q32.2 |
benign|likely benign |
NM_005259.3(MSTN):c.*259A>G | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000275243] | Chr2:190056999 [GRCh38] Chr2:190921725 [GRCh37] Chr2:2q32.2 |
likely benign|uncertain significance |
NM_005259.3(MSTN):c.*41G>T | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000276588] | Chr2:190057217 [GRCh38] Chr2:190921943 [GRCh37] Chr2:2q32.2 |
likely benign|uncertain significance |
NM_005259.3(MSTN):c.*1362A>G | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000332447] | Chr2:190055896 [GRCh38] Chr2:190920622 [GRCh37] Chr2:2q32.2 |
benign|likely benign |
NM_005259.3(MSTN):c.-44GAA[1] | microsatellite | Myostatin-related muscle hypertrophy [RCV000397391] | Chr2:190062635..190062637 [GRCh38] Chr2:190927361..190927363 [GRCh37] Chr2:2q32.2 |
likely benign |
NM_005259.3(MSTN):c.*395A>C | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000398216] | Chr2:190056863 [GRCh38] Chr2:190921589 [GRCh37] Chr2:2q32.2 |
benign |
NM_005259.3(MSTN):c.*697T>C | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000398220] | Chr2:190056561 [GRCh38] Chr2:190921287 [GRCh37] Chr2:2q32.2 |
likely benign|uncertain significance |
NM_005259.3(MSTN):c.*1145del | deletion | Myostatin-related muscle hypertrophy [RCV000338280] | Chr2:190056113 [GRCh38] Chr2:190920839 [GRCh37] Chr2:2q32.2 |
likely benign |
NM_005259.3(MSTN):c.*742C>T | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000339305]|not provided [RCV004708447] | Chr2:190056516 [GRCh38] Chr2:190921242 [GRCh37] Chr2:2q32.2 |
benign |
NM_005259.3(MSTN):c.180C>T (p.Ile60=) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000404459]|not provided [RCV000885041] | Chr2:190062417 [GRCh38] Chr2:190927143 [GRCh37] Chr2:2q32.2 |
benign|likely benign |
NM_005259.3(MSTN):c.*574G>A | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000304618] | Chr2:190056684 [GRCh38] Chr2:190921410 [GRCh37] Chr2:2q32.2 |
likely benign |
NM_005259.3(MSTN):c.*1514C>G | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000385328] | Chr2:190055744 [GRCh38] Chr2:190920470 [GRCh37] Chr2:2q32.2 |
benign |
NM_005259.3(MSTN):c.*493G>A | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000363928] | Chr2:190056765 [GRCh38] Chr2:190921491 [GRCh37] Chr2:2q32.2 |
benign |
NM_005259.3(MSTN):c.*273C>G | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000365232]|not provided [RCV004708449] | Chr2:190056985 [GRCh38] Chr2:190921711 [GRCh37] Chr2:2q32.2 |
benign|likely benign |
NM_005259.3(MSTN):c.*290C>T | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000310379]|not provided [RCV004708448] | Chr2:190056968 [GRCh38] Chr2:190921694 [GRCh37] Chr2:2q32.2 |
benign|likely benign |
NM_005259.3(MSTN):c.*1450T>C | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000295685] | Chr2:190055808 [GRCh38] Chr2:190920534 [GRCh37] Chr2:2q32.2 |
benign|likely benign |
NM_005259.3(MSTN):c.*135G>A | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000330435]|not provided [RCV004708450] | Chr2:190057123 [GRCh38] Chr2:190921849 [GRCh37] Chr2:2q32.2 |
benign |
NM_005259.3(MSTN):c.-17A>C | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000350365] | Chr2:190062613 [GRCh38] Chr2:190927339 [GRCh37] Chr2:2q32.2 |
benign|uncertain significance |
NM_005259.3(MSTN):c.*1332A>G | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000373119] | Chr2:190055926 [GRCh38] Chr2:190920652 [GRCh37] Chr2:2q32.2 |
benign |
NM_005259.3(MSTN):c.234A>G (p.Arg78=) | single nucleotide variant | not provided [RCV000594454] | Chr2:190062363 [GRCh38] Chr2:190927089 [GRCh37] Chr2:2q32.2 |
uncertain significance |
GRCh37/hg19 2p25.3-q37.3(chr2:14238-243048760)x3 | copy number gain | not provided [RCV000752802] | Chr2:14238..243048760 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
NM_005259.3(MSTN):c.*923T>C | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000284237] | Chr2:190056335 [GRCh38] Chr2:190921061 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.*1073G>T | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000405515] | Chr2:190056185 [GRCh38] Chr2:190920911 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.*121A>G | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000371068] | Chr2:190057137 [GRCh38] Chr2:190921863 [GRCh37] Chr2:2q32.2 |
uncertain significance |
GRCh37/hg19 2q31.1-35(chr2:169829974-215521436)x3 | copy number gain | See cases [RCV000448271] | Chr2:169829974..215521436 [GRCh37] Chr2:2q31.1-35 |
pathogenic |
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384) | copy number gain | See cases [RCV000512056] | Chr2:12771..242783384 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
GRCh37/hg19 2p25.3-q37.3(chr2:12771-242783384)x3 | copy number gain | See cases [RCV000511212] | Chr2:12771..242783384 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
GRCh37/hg19 2p25.3-q37.3(chr2:15672-243101834)x3 | copy number gain | not provided [RCV000752804] | Chr2:15672..243101834 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
NM_005259.3(MSTN):c.748-128C>T | single nucleotide variant | not provided [RCV001707942] | Chr2:190057766 [GRCh38] Chr2:190922492 [GRCh37] Chr2:2q32.2 |
benign |
Single allele | duplication | Neurodevelopmental disorder [RCV000787403] | Chr2:188926928..225298653 [GRCh37] Chr2:2q32.1-36.2 |
pathogenic |
GRCh37/hg19 2q24.3-32.3(chr2:167329586-192756373)x1 | copy number loss | not provided [RCV000848216] | Chr2:167329586..192756373 [GRCh37] Chr2:2q24.3-32.3 |
pathogenic |
NM_005259.3(MSTN):c.*695A>C | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001137516]|not provided [RCV004694848] | Chr2:190056563 [GRCh38] Chr2:190921289 [GRCh37] Chr2:2q32.2 |
uncertain significance |
GRCh37/hg19 2q24.2-34(chr2:163233162-211927188)x3 | copy number gain | not provided [RCV001005349] | Chr2:163233162..211927188 [GRCh37] Chr2:2q24.2-34 |
pathogenic |
NM_005259.3(MSTN):c.1085G>A (p.Gly362Glu) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001140503] | Chr2:190057301 [GRCh38] Chr2:190922027 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.*784G>A | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001137515] | Chr2:190056474 [GRCh38] Chr2:190921200 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.374-84A>T | single nucleotide variant | not provided [RCV001669126] | Chr2:190060519 [GRCh38] Chr2:190925245 [GRCh37] Chr2:2q32.2 |
benign |
NM_005259.3(MSTN):c.798G>A (p.Arg266=) | single nucleotide variant | not provided [RCV000973312] | Chr2:190057588 [GRCh38] Chr2:190922314 [GRCh37] Chr2:2q32.2 |
benign |
NM_005259.3(MSTN):c.*1316C>G | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001142256] | Chr2:190055942 [GRCh38] Chr2:190920668 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.373+90del | deletion | not provided [RCV001539856] | Chr2:190062134 [GRCh38] Chr2:190926860 [GRCh37] Chr2:2q32.2 |
benign |
NM_005259.3(MSTN):c.*1273C>T | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001142257] | Chr2:190055985 [GRCh38] Chr2:190920711 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.*336C>A | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001139724] | Chr2:190056922 [GRCh38] Chr2:190921648 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.*127T>C | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001139725] | Chr2:190057131 [GRCh38] Chr2:190921857 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.747+8A>G | single nucleotide variant | MSTN-related disorder [RCV003928739]|Myostatin-related muscle hypertrophy [RCV001142348] | Chr2:190060054 [GRCh38] Chr2:190924780 [GRCh37] Chr2:2q32.2 |
benign|likely benign |
GRCh37/hg19 2q31.1-32.3(chr2:174690039-195521582)x1 | copy number loss | not provided [RCV001005359] | Chr2:174690039..195521582 [GRCh37] Chr2:2q31.1-32.3 |
pathogenic |
NM_005259.3(MSTN):c.*1063A>G | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001137514] | Chr2:190056195 [GRCh38] Chr2:190920921 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.547G>C (p.Gly183Arg) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001142349] | Chr2:190060262 [GRCh38] Chr2:190924988 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.513G>A (p.Val171=) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001142351] | Chr2:190060296 [GRCh38] Chr2:190925022 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.-99G>A | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001139829] | Chr2:190062695 [GRCh38] Chr2:190927421 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.897C>T (p.Ile299=) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001140504] | Chr2:190057489 [GRCh38] Chr2:190922215 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.796A>C (p.Arg266=) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001140505] | Chr2:190057590 [GRCh38] Chr2:190922316 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.516A>C (p.Gln172His) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001142350] | Chr2:190060293 [GRCh38] Chr2:190925019 [GRCh37] Chr2:2q32.2 |
likely benign |
NM_005259.3(MSTN):c.*40G>T | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001140502] | Chr2:190057218 [GRCh38] Chr2:190921944 [GRCh37] Chr2:2q32.2 |
benign |
GRCh37/hg19 2q32.1-34(chr2:185697659-213002074) | copy number loss | Chromosome 2q32-q33 deletion syndrome [RCV002280608] | Chr2:185697659..213002074 [GRCh37] Chr2:2q32.1-34 |
pathogenic |
GRCh37/hg19 2q31.2-37.3(chr2:178397959-243007457)x3 | copy number gain | See cases [RCV001263052] | Chr2:178397959..243007457 [GRCh37] Chr2:2q31.2-37.3 |
pathogenic |
GRCh37/hg19 2q32.2-33.1(chr2:190345272-200212289) | copy number loss | Chromosome 2q32-q33 deletion syndrome [RCV001255693] | Chr2:190345272..200212289 [GRCh37] Chr2:2q32.2-33.1 |
pathogenic |
GRCh37/hg19 2q32.1-33.1(chr2:188294864-197731939)x3 | copy number gain | not provided [RCV001258567] | Chr2:188294864..197731939 [GRCh37] Chr2:2q32.1-33.1 |
likely pathogenic |
NM_005259.3(MSTN):c.374-130G>A | single nucleotide variant | not provided [RCV001539260] | Chr2:190060565 [GRCh38] Chr2:190925291 [GRCh37] Chr2:2q32.2 |
benign |
GRCh37/hg19 2q31.1-35(chr2:169829974-215521436) | copy number gain | not specified [RCV002053265] | Chr2:169829974..215521436 [GRCh37] Chr2:2q31.1-35 |
pathogenic |
GRCh37/hg19 2q32.2-34(chr2:189909904-209468383)x1 | copy number loss | not provided [RCV002473800] | Chr2:189909904..209468383 [GRCh37] Chr2:2q32.2-34 |
pathogenic |
GRCh37/hg19 2q32.2(chr2:190819533-191102271)x3 | copy number gain | not provided [RCV002473459] | Chr2:190819533..191102271 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.701G>A (p.Gly234Asp) | single nucleotide variant | not specified [RCV004178217] | Chr2:190060108 [GRCh38] Chr2:190924834 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.739G>A (p.Asp247Asn) | single nucleotide variant | not specified [RCV004224452] | Chr2:190060070 [GRCh38] Chr2:190924796 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.529A>C (p.Ile177Leu) | single nucleotide variant | not specified [RCV004210918] | Chr2:190060280 [GRCh38] Chr2:190925006 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.89A>C (p.Lys30Thr) | single nucleotide variant | not specified [RCV004233950] | Chr2:190062508 [GRCh38] Chr2:190927234 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.639A>C (p.Gln213His) | single nucleotide variant | not specified [RCV004145856] | Chr2:190060170 [GRCh38] Chr2:190924896 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.496C>T (p.Pro166Ser) | single nucleotide variant | not specified [RCV004225387] | Chr2:190060313 [GRCh38] Chr2:190925039 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.1112G>A (p.Arg371His) | single nucleotide variant | not specified [RCV004223262] | Chr2:190057274 [GRCh38] Chr2:190922000 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.916G>A (p.Ala306Thr) | single nucleotide variant | not specified [RCV004274849] | Chr2:190057470 [GRCh38] Chr2:190922196 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.150T>C (p.Ser50=) | single nucleotide variant | not provided [RCV003440109] | Chr2:190062447 [GRCh38] Chr2:190927173 [GRCh37] Chr2:2q32.2 |
likely benign |
NM_005259.3(MSTN):c.194G>A (p.Arg65His) | single nucleotide variant | MSTN-related disorder [RCV003964644] | Chr2:190062403 [GRCh38] Chr2:190927129 [GRCh37] Chr2:2q32.2 |
likely benign |
NM_005259.3(MSTN):c.1101G>A (p.Met367Ile) | single nucleotide variant | not specified [RCV004503695] | Chr2:190057285 [GRCh38] Chr2:190922011 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.721T>C (p.Phe241Leu) | single nucleotide variant | not specified [RCV004503715] | Chr2:190060088 [GRCh38] Chr2:190924814 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.995C>G (p.Pro332Arg) | single nucleotide variant | not specified [RCV004503723] | Chr2:190057391 [GRCh38] Chr2:190922117 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.538A>G (p.Met180Val) | single nucleotide variant | not specified [RCV004503708] | Chr2:190060271 [GRCh38] Chr2:190924997 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.1111C>T (p.Arg371Cys) | single nucleotide variant | not specified [RCV004503696] | Chr2:190057275 [GRCh38] Chr2:190922001 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.164C>T (p.Ala55Val) | single nucleotide variant | not specified [RCV004503699] | Chr2:190062433 [GRCh38] Chr2:190927159 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.406A>C (p.Lys136Gln) | single nucleotide variant | not specified [RCV004503702] | Chr2:190060403 [GRCh38] Chr2:190925129 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.45G>A (p.Leu15=) | single nucleotide variant | MSTN-related disorder [RCV004759121] | Chr2:190062552 [GRCh38] Chr2:190927278 [GRCh37] Chr2:2q32.2 |
likely benign |
NM_005259.3(MSTN):c.634T>G (p.Leu212Val) | single nucleotide variant | not specified [RCV004503710] | Chr2:190060175 [GRCh38] Chr2:190924901 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.1062T>C (p.Asn354=) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000317681] | Chr2:190057324 [GRCh38] Chr2:190922050 [GRCh37] Chr2:2q32.2 |
likely benign|uncertain significance |
NM_005259.3(MSTN):c.490G>A (p.Glu164Lys) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV000376122]|not provided [RCV000960832] | Chr2:190060319 [GRCh38] Chr2:190925045 [GRCh37] Chr2:2q32.2 |
benign|likely benign |
GRCh37/hg19 2q32.2-33.1(chr2:189490490-200615496)x1 | copy number loss | not provided [RCV000740789] | Chr2:189490490..200615496 [GRCh37] Chr2:2q32.2-33.1 |
pathogenic |
NM_005259.3(MSTN):c.98T>C (p.Val33Ala) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001137605] | Chr2:190062499 [GRCh38] Chr2:190927225 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.453A>G (p.Val151=) | single nucleotide variant | Myostatin-related muscle hypertrophy [RCV001137604] | Chr2:190060356 [GRCh38] Chr2:190925082 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NC_000002.11:g.(?_189839216)_(192012929_?)dup | duplication | Immunodeficiency 31B [RCV003107719]|not provided [RCV003113217] | Chr2:189839216..192012929 [GRCh37] Chr2:2q32.2-32.3 |
uncertain significance|no classifications from unflagged records |
GRCh37/hg19 2p25.3-q37.3(chr2:1-243199373) | copy number gain | Mosaic trisomy 2 [RCV002280628] | Chr2:1..243199373 [GRCh37] Chr2:2p25.3-q37.3 |
pathogenic |
GRCh37/hg19 2q32.1-33.1(chr2:187152754-199960525)x1 | copy number loss | not provided [RCV002472632] | Chr2:187152754..199960525 [GRCh37] Chr2:2q32.1-33.1 |
pathogenic |
NM_001042519.2(C2orf88):c.138G>C (p.Glu46Asp) | single nucleotide variant | not specified [RCV004076553] | Chr2:190199998 [GRCh38] Chr2:191064724 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.881G>C (p.Gly294Ala) | single nucleotide variant | not specified [RCV004178386] | Chr2:190057505 [GRCh38] Chr2:190922231 [GRCh37] Chr2:2q32.2 |
uncertain significance |
NM_005259.3(MSTN):c.730C>G (p.Pro244Ala) | single nucleotide variant | not specified [RCV004299914] | Chr2:190060079 [GRCh38] Chr2:190924805 [GRCh37] Chr2:2q32.2 |
uncertain significance |
GRCh37/hg19 2q32.1-36.1(chr2:186698504-223918111)x3 | copy number gain | See cases [RCV003329558] | Chr2:186698504..223918111 [GRCh37] Chr2:2q32.1-36.1 |
pathogenic |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
The following QTLs overlap with this region. | Full Report | CSV | TAB | Printer | Gviewer |
RH94194 |
|
||||||||||||||||||||||||||||||||||||||||
RH93597 |
|
||||||||||||||||||||||||||||||||||||||||
G59581 |
|
||||||||||||||||||||||||||||||||||||||||
SHGC-35899 |
|
||||||||||||||||||||||||||||||||||||||||
RH69372 |
|
||||||||||||||||||||||||||||||||||||||||
WIAF-2135 |
|
adipose tissue
|
alimentary part of gastrointestinal system
|
appendage
|
circulatory system
|
ectoderm
|
endocrine system
|
endoderm
|
entire extraembryonic component
|
exocrine system
|
hemolymphoid system
|
hepatobiliary system
|
integumental system
|
mesenchyme
|
mesoderm
|
musculoskeletal system
|
nervous system
|
pharyngeal arch
|
renal system
|
reproductive system
|
respiratory system
|
sensory system
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1204 | 2435 | 2788 | 2249 | 4951 | 1720 | 2343 | 3 | 624 | 1926 | 464 | 2258 | 7266 | 6439 | 49 | 3724 | 1 | 848 | 1738 | 1610 | 173 |
Ensembl Acc Id: | ENST00000340623 ⟹ ENSP00000345107 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000396974 ⟹ ENSP00000380172 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000409545 ⟹ ENSP00000386976 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000409870 ⟹ ENSP00000386649 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000443551 ⟹ ENSP00000405225 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000450357 ⟹ ENSP00000394370 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000478197 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000490033 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000495546 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_001042519 ⟹ NP_001035984 | ||||||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_001042520 ⟹ NP_001035985 | ||||||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_001042521 ⟹ NP_001035986 | ||||||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_032321 ⟹ NP_115697 | ||||||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | XM_011511983 ⟹ XP_011510285 | ||||||||
Type: | CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XM_047446008 ⟹ XP_047301964 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_047446009 ⟹ XP_047301965 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NP_001035986 ⟸ NM_001042521 |
- UniProtKB: | P0C876 (UniProtKB/Swiss-Prot), D3DPI3 (UniProtKB/Swiss-Prot), Q53TC7 (UniProtKB/Swiss-Prot), Q9BSF0 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | NP_001035984 ⟸ NM_001042519 |
- UniProtKB: | P0C876 (UniProtKB/Swiss-Prot), D3DPI3 (UniProtKB/Swiss-Prot), Q53TC7 (UniProtKB/Swiss-Prot), Q9BSF0 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | NP_115697 ⟸ NM_032321 |
- UniProtKB: | P0C876 (UniProtKB/Swiss-Prot), D3DPI3 (UniProtKB/Swiss-Prot), Q53TC7 (UniProtKB/Swiss-Prot), Q9BSF0 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | NP_001035985 ⟸ NM_001042520 |
- UniProtKB: | P0C876 (UniProtKB/Swiss-Prot), D3DPI3 (UniProtKB/Swiss-Prot), Q53TC7 (UniProtKB/Swiss-Prot), Q9BSF0 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | XP_011510285 ⟸ XM_011511983 |
- Peptide Label: | isoform X1 |
- UniProtKB: | P0C876 (UniProtKB/Swiss-Prot), D3DPI3 (UniProtKB/Swiss-Prot), Q53TC7 (UniProtKB/Swiss-Prot), Q9BSF0 (UniProtKB/Swiss-Prot) |
- Sequence: |
Ensembl Acc Id: | ENSP00000394370 ⟸ ENST00000450357 |
Ensembl Acc Id: | ENSP00000405225 ⟸ ENST00000443551 |
Ensembl Acc Id: | ENSP00000345107 ⟸ ENST00000340623 |
Ensembl Acc Id: | ENSP00000386649 ⟸ ENST00000409870 |
Ensembl Acc Id: | ENSP00000386976 ⟸ ENST00000409545 |
Ensembl Acc Id: | ENSP00000380172 ⟸ ENST00000396974 |
RefSeq Acc Id: | XP_047301964 ⟸ XM_047446008 |
- Peptide Label: | isoform X1 |
- UniProtKB: | Q9BSF0 (UniProtKB/Swiss-Prot), P0C876 (UniProtKB/Swiss-Prot), D3DPI3 (UniProtKB/Swiss-Prot), Q53TC7 (UniProtKB/Swiss-Prot) |
RefSeq Acc Id: | XP_047301965 ⟸ XM_047446009 |
- Peptide Label: | isoform X1 |
- UniProtKB: | Q9BSF0 (UniProtKB/Swiss-Prot), P0C876 (UniProtKB/Swiss-Prot), D3DPI3 (UniProtKB/Swiss-Prot), Q53TC7 (UniProtKB/Swiss-Prot) |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q9BSF0-F1-model_v2 | AlphaFold | Q9BSF0 | 1-95 | view protein structure |
RGD ID: | 6862376 | ||||||||
Promoter ID: | EPDNEW_H4334 | ||||||||
Type: | initiation region | ||||||||
Name: | C2orf88_1 | ||||||||
Description: | chromosome 2 open reading frame 88 | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
RGD ID: | 6797337 | ||||||||
Promoter ID: | HG_KWN:36362 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, K562, Lymphoblastoid | ||||||||
Transcripts: | ENST00000409870, NM_001042519, NM_032321 | ||||||||
Position: |
|
RGD ID: | 6797813 | ||||||||
Promoter ID: | HG_KWN:36364 | ||||||||
Type: | Non-CpG | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | K562 | ||||||||
Transcripts: | UC010FSA.1 | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:28191 | AgrOrtholog |
COSMIC | C2orf88 | COSMIC |
Ensembl Genes | ENSG00000187699 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Ensembl Transcript | ENST00000340623 | ENTREZGENE |
ENST00000340623.4 | UniProtKB/Swiss-Prot | |
ENST00000396974 | ENTREZGENE | |
ENST00000396974.2 | UniProtKB/Swiss-Prot | |
ENST00000409545.2 | UniProtKB/TrEMBL | |
ENST00000409870.1 | UniProtKB/Swiss-Prot | |
ENST00000443551 | ENTREZGENE | |
ENST00000443551.2 | UniProtKB/Swiss-Prot | |
ENST00000450357.5 | UniProtKB/TrEMBL | |
GTEx | ENSG00000187699 | GTEx |
HGNC ID | HGNC:28191 | ENTREZGENE |
Human Proteome Map | C2orf88 | Human Proteome Map |
InterPro | Small_membr_AKAP | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
KEGG Report | hsa:84281 | UniProtKB/Swiss-Prot |
NCBI Gene | 84281 | ENTREZGENE |
OMIM | 615117 | OMIM |
PANTHER | PTHR36471 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
SMALL MEMBRANE A-KINASE ANCHOR PROTEIN | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Pfam | SmAKAP | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
PharmGKB | PA164717227 | PharmGKB |
UniProt | C9JS57_HUMAN | UniProtKB/TrEMBL |
D3DPI3 | ENTREZGENE | |
H7BZ15_HUMAN | UniProtKB/TrEMBL | |
P0C876 | ENTREZGENE | |
Q53TC7 | ENTREZGENE | |
Q9BSF0 | ENTREZGENE, UniProtKB/Swiss-Prot | |
UniProt Secondary | D3DPI3 | UniProtKB/Swiss-Prot |
P0C876 | UniProtKB/Swiss-Prot | |
Q53TC7 | UniProtKB/Swiss-Prot |